Crossmark

Management of the axilla in breast cancer patients: critical review, regional modified Delphi consensus and implementation in the Tuscan breast network

Crossref DOI link: https://doi.org/10.1007/s11547-024-01818-7

Published Online: 2024-04-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ghilli, Matteo https://orcid.org/0000-0001-5536-7377
Becherini, Carlotta

Meattini, Icro

Angiolini, Catia

Bengala, Carmelo

Marconi, Aroldo

Galli, Lorenzo

Angiolucci, Giovanni

Coltelli, Luigi

Borghesi, Simona

Lastrucci, Luciana

Manca, Gianpiero

Bianchi, Simonetta

Doria, Morena

Casella, Donato

Marotti, Lorenza

Amunni, Gianni

Roncella, Manuela
License Information

Text and Data Mining valid from 2024-04-29

Version of Record valid from 2024-04-29
More Information

Article History

Received: 27 December 2023

Accepted: 16 April 2024

First Online: 29 April 2024

Declarations

:

: Icro Meattini declares advisory boards supported by Eli Lilly, Novartis, Pfizer, Pierre Fabre, SeaGen, Daiichi Sankyo and AstraZeneca. CB declares honoraria supported by Eli Lilly, Novartis, Pfizer and Amgen. The other authors have no relevant financial or non-financial interest to disclose.

: Ethical approval was not necessary for this kind of scientific work.

: Not applicable.

Document is current

Any future updates will be listed below